Amprion

Revolutionizing neurodegenerative disease diagnosis with advanced α-synuclein detection technology

placeHouston, Texas, United States calendar_todayFounded 2006 groups34 employees language ampriondx.com

Registered entities

Innovation

16 patent families (9 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 523 times.

YearFilings
20163
20171
20184
20193
20202
202110
20225
20235
20248
20255
20261

Social engagement

Social engagement: 3.1K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Formationve.

Investor typeCountShare
Other / undisclosed4100%
Coming soon